Psychedelic Integration: A Complete Guide to the First Six Months

Psychedelic integration is the work of turning what happened during an altered state into something that holds up in ordinary life. Not the memory of it. The behaviour, the relationships, the decisions. This guide is about the part almost nobody plans for: what you actually do in the days, weeks and months after, and in what order.

Most people prepare intensively for the experience and improvise everything that comes after. That asymmetry is where the value gets lost, and occasionally where the harm shows up.

Integration is a process with a timeline, not a single conversation. Different things matter in the first 72 hours than in month four.

The strongest research on psychedelics comes from supervised clinical trials. It does not automatically transfer to retreats, ceremonies or unsupervised use, and it does not tell us how well any particular integration method works.

Extended difficulties after psychedelic use are documented in the research literature, are usually not permanent, and respond to structure and social support.

Integration is education and coaching, not therapy or medical treatment. Some situations need a licensed clinician instead, and knowing which ones is part of the work.

If you take nothing else from this: schedule the boring parts. Sleep, food, movement, contact with people who know you. Meaning-making happens on top of a stable baseline, not instead of one.

The term is used loosely, which is a problem. A 2022 concept analysis in Frontiers in Psychology reviewed the existing definitions and models and found that the field had accumulated many overlapping meanings, offered by therapists, coaches and self-guided practitioners alike (Bathje, Majeski and Kudowor, 2022). Their synthesis lands on something usable: integration is the ongoing process of making sense of a psychedelic experience and translating it into changes in how a person lives.

Two distinctions are worth holding onto.

Integration is not the same as processing. Processing is understanding what happened. Integration is what changes because of it. A person can process an experience beautifully and integrate nothing.

Integration is also not the same as psychotherapy. Clinicians working with people who use psychedelics have described a model called Psychedelic Harm Reduction and Integration, which combines harm reduction principles with therapeutic support (Gorman et al., 2021). That model is written for licensed clinicians treating patients. Coaching and peer support occupy a different, narrower lane, and the boundary matters more than most people in this space admit.

Treat the six months after an experience as four phases with different jobs. This staging is a practical framework built from published accounts of post-experience difficulty and coping, plus common patterns in coaching practice. It is not a validated clinical protocol.

The nervous system is still settling. Sleep is often disrupted, emotions run wide, and a strong sense of clarity can coexist with genuinely poor judgement.

The job here is regulation, not insight. Protect sleep. Eat properly. Move gently. Stay near people who know your baseline. Write things down without interpreting them.

The most common expensive mistake happens in this window: acting on a large, irreversible decision while still in the afterglow. Quitting the job, ending the relationship, announcing the new life direction. Give big decisions a minimum of two to four weeks before you commit. If the insight is real, it will survive the wait. If it does not survive the wait, you have your answer.

This is where the actual work sits, and where most people stop.

Pick one or two concrete behaviours, not ten. An insight like "I have been avoiding my father" becomes a scheduled phone call. "I need more space" becomes a specific hour blocked on a specific day. An insight without a calendar entry has an extremely short half-life.

There is a plausible biological argument for why this window matters. Work in mice found that several psychedelics reopened a critical period for social reward learning, with the length of that window differing by substance (Nardou et al., 2023). That is rodent research and should not be read as a human timetable. But it fits what practitioners observe: people are unusually responsive to new patterns for a while, and that responsiveness is finite.

The elevated state fades. This is normal and not a failure. What should remain is the behaviour, not the feeling.

The useful question in this phase is unglamorous: what am I doing differently that I was not doing before? If the honest answer is nothing, the experience was interesting rather than transformative, and that is worth naming without shame.

This is also when unfinished material tends to surface. Grief that got postponed. A relationship that was already ending. Integration in this phase often looks less like revelation and more like ordinary, structured follow-through.

Some experiences keep releasing meaning for years. The risk here is the opposite of the earlier one: building an identity around the experience rather than around the life it was supposed to improve. Anti-hype applies to your own story too.

First 72 hours. The job is to stabilise. What helps: sleep, food, gentle movement, trusted company, unfiltered notes. What backfires: big decisions, heavy analysis, taking more, broadcasting on social media.

Weeks one to four. The job is to translate. What helps: one or two specific behaviour changes with dates attached, structured reflection, honest conversation. What backfires: collecting insights without acting, isolating, treating intensity as proof.

Months two to six. The job is to consolidate. What helps: reviewing what actually changed, addressing what surfaced, keeping the boring foundations in place. What backfires: chasing the next experience to recover the feeling.

The long tail. The job is to keep perspective. What helps: measuring by ordinary life, periodic honest review. What backfires: building an identity on the experience, evangelising, dismissing conventional support.

This is the part most integration content skips, so here it is directly.

Clinical trials are not retreats. The headline efficacy findings come from supervised settings with medical screening, prepared participants and trained staff present. In one of the larger trials, 233 adults with treatment-resistant depression received a single dose of synthetic psilocybin at 25 mg, 10 mg or 1 mg alongside psychological support, across 22 sites in 10 countries (Goodwin et al., 2022). The 25 mg dose produced a significantly greater reduction in depression scores at three weeks than the 1 mg comparator. It also produced adverse events: 77% of participants reported some adverse event, and suicidal ideation or self-injurious behaviour was numerically more frequent in the higher-dose groups. Sustained response at 12 weeks was not established. That is a serious result in both directions, and it says nothing about unsupervised use.

Difficult experiences are common and not automatically damaging. A survey of 1,993 people describing their single most challenging psilocybin mushroom experience found that 39% rated it among the five most challenging experiences of their life, and 11% said they had put themselves or others at physical risk. Risk was higher with larger estimated doses, longer and more difficult experiences, and the absence of physical comfort and social support. Despite this, 84% reported benefiting from the experience (Carbonaro et al., 2016). This is a self-selected retrospective survey, so it cannot tell us how often this happens in the general population.

Extended difficulties are real, documented, and usually workable. A mixed-methods study of 608 people reporting difficulties that persisted after the experience itself found the most common forms were anxiety and fear, existential struggle, social disconnection, and depersonalisation or derealisation (Evans et al., 2023). A companion analysis of the same cohort found that the strategies people rated most helpful were largely ordinary: meditation or prayer, reading and journaling, and social support and connection (Robinson et al., 2024). A separate small qualitative study, deliberately recruiting only people with negative responses lasting more than 72 hours, gathered 32 survey responses and 15 interviews and described symptoms including derealisation and intrusive re-experiencing (Bremler et al., 2023). All of these are self-selected samples recruited online. They describe what difficulty looks like and what helps. They cannot tell you how likely difficulty is.

Mechanism research is suggestive, not settled. An international survey of 985 people who had used a psychedelic found that increases in psychological flexibility statistically mediated the relationship between mystical and insightful acute effects and self-reported decreases in depression and anxiety (Davis, Barrett and Griffiths, 2020). Mediation in a cross-sectional retrospective survey is an association, not a demonstrated causal chain.

Integration itself is under-studied. This is the honest bottom line. Integration practices are inconsistently defined and inconsistently reported in clinical trials, which makes it genuinely difficult to say how much any specific integration method contributes to outcomes. Anyone telling you their integration protocol is evidence-based in the way a medication is evidence-based is overstating the case, and that includes anyone in this field selling integration coaching.

Myth: the experience does the healing. Evidence: acute effects are associated with reported improvement, but in survey data that association runs through things like psychological flexibility, and durability is not guaranteed (Davis et al., 2020; Goodwin et al., 2022).

Myth: a difficult experience means something went wrong. Evidence: difficult experiences are frequently reported as beneficial afterwards, though the risk of harm during them is real and rises without physical comfort and social support (Carbonaro et al., 2016).

Myth: integration means talking about it. Evidence: people with extended difficulties reported the most help from meditation or prayer, reading and journaling, and social connection (Robinson et al., 2024). Talking is one input, not the mechanism.

Myth: anyone can integrate anything with the right support. Evidence: some presentations need licensed clinical care. Trial data include serious psychiatric adverse events (Goodwin et al., 2022).

Myth: more experiences means more integration. Evidence: frequent use in the period before a difficult episode features in qualitative accounts of prolonged adverse responses (Bremler et al., 2023). Nothing supports repetition as a substitute for follow-through.

Three questions, asked at week two, week six and month four. Written answers, not mental ones.

1. What did I see? Describe the content plainly, without adding significance. Just the material.

2. What does it ask of me? Convert it into a demand on your time or behaviour. If it does not make a demand, it is a memory, not an instruction.

3. What did I actually do? This is the only question that scores. Compare against the previous round.

If question three comes back empty three times, the problem is not that you need another experience. It is that behaviour change is a skill, and skills need structure, not intensity.

Integration coaching is education and support. It is not therapy, not diagnosis, and not medical care. That is a real boundary, not a legal formality.

Use the following as a triage check on yourself, or on someone you are supporting.

Green, ordinary integration territory: emotional sensitivity, vivid memories, unresolved questions, motivation that fluctuates, mild sleep disruption that settles within days.

Amber, get more support and slow down: sleep disruption persisting past two weeks, anxiety that is not easing, persistent depersonalisation or derealisation, social withdrawal, escalating substance use, or fixed certainty about your own grand significance that the people around you find alarming. Amber means stop planning the next experience and add human support, ideally including someone qualified.

Red, seek licensed clinical or medical help now: thoughts of harming yourself or others, hallucinations or fixed false beliefs persisting outside the experience, inability to function day to day, signs of mania, or severe or worsening depression. Use official local emergency or mental health services in your country. I do not publish phone numbers here because they change and vary by jurisdiction, and a wrong number in a crisis is worse than none.

Contraindication screening belongs before an experience, not after, but it stays relevant afterwards. A personal or family history of psychosis, schizophrenia or bipolar disorder, and current serious psychiatric instability, are standard exclusions in clinical trials for good reason. Screening is not a formality.

On law: classic psychedelics and MDMA are controlled substances in most of Europe, and national laws, penalties and any research or medical exemptions differ substantially between countries and change over time. Check your own jurisdiction. Nothing here encourages illegal activity.

There is no validated timeline. In practice the first month carries most of the behavioural work, and six months is a reasonable horizon for judging whether anything durable changed. Some people work with the same material for years.

Often, yes. The cohort study of people with extended difficulties found the most helpful strategies included self-directed ones such as meditation, reading and journaling, alongside social support (Robinson et al., 2024). Working with someone helps mainly when you are stuck, when you are isolated, or when you keep re-deciding the same thing without acting. If you are in amber or red territory above, self-directed work is not the right call.

No. A coach does not diagnose, does not treat mental illness, and does not provide psychotherapy. If what you need is treatment for a psychiatric condition, you need a licensed clinician, and a competent coach will tell you so.

That happens, and it is not a personal failure. It usually means the honest next step is ordinary: sleep, structure, relationships, and the specific behaviour you have been avoiding. Chasing another experience to manufacture a feeling is the most predictable way to waste both the money and the risk.

Integration sits on top of a functioning baseline. If sleep, food and basic stability are broken, fix those first. Meaning-making does not work well on a dysregulated system.

If you are trying to work out whether an experience is a reasonable idea for you, or whether what you are dealing with right now is green, amber or red, start with the free safety self-assessment: entheogen.expert/safety. It takes a few minutes, it is not a sales funnel, and it will tell you plainly if the answer is "not you, not now."

If you want to know who is writing this and why, my background is here: my story. If you decide you want structured support, the services page explains what that involves.

Vladislav Andreev is a Certified Psychedelic Coach (Psychedelic Coaching Institute), harm-reduction educator and executive coach based in Barcelona. He works in coaching and public education only. He is not a doctor, psychiatrist, psychologist or psychotherapist, does not provide or source substances, and does not give medical advice.

Reviewed for scope by Vladislav Andreev, Certified Psychedelic Coach, harm-reduction educator, Barcelona.

Want to reflect on a psychedelic experience in a structured, non-clinical setting?

Explore psychedelic integration coaching or review the psychedelic safety guidance before booking.

About the author

Vladislav Andreev is an executive coach and psychedelic integration educator. His work focuses on structured reflection, practical behaviour change, and clear boundaries between coaching, therapy, and medical care.

This article is educational and does not provide medical advice, diagnosis, or treatment.

1. Bathje GJ, Majeski E, Kudowor M. Psychedelic integration: an analysis of the concept and its practice. Frontiers in Psychology. 2022;13:824077. doi:10.3389/fpsyg.2022.824077

2. Gorman I, Nielson EM, Molinar A, Cassidy K, Sabbagh J. Psychedelic Harm Reduction and Integration: a transtheoretical model for clinical practice. Frontiers in Psychology. 2021;12:645246. doi:10.3389/fpsyg.2021.645246

3. Goodwin GM, et al. Single-dose psilocybin for a treatment-resistant episode of major depression. New England Journal of Medicine. 2022;387(18):1637-1648. doi:10.1056/NEJMoa2206443

4. Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR. Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences. Journal of Psychopharmacology. 2016;30(12):1268-1278. doi:10.1177/0269881116662634

5. Evans J, Robinson OC, Ketzitzidou Argyri E, et al. Extended difficulties following the use of psychedelic drugs: a mixed methods study. PLoS ONE. 2023;18(10):e0293349. doi:10.1371/journal.pone.0293349

6. Robinson OC, Evans J, Luke D, et al. Coming back together: a qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs. Frontiers in Psychology. 2024;15:1369715. doi:10.3389/fpsyg.2024.1369715

7. Bremler R, Katati N, Shergill P, Erritzoe D, Carhart-Harris RL. Case analysis of long-term negative psychological responses to psychedelics. Scientific Reports. 2023;13:15998. doi:10.1038/s41598-023-41145-x

8. Davis AK, Barrett FS, Griffiths RR. Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. Journal of Contextual Behavioral Science. 2020;15:39-45. doi:10.1016/j.jcbs.2019.11.004

9. Nardou R, Sawyer E, Song YJ, et al. Psychedelics reopen the social reward learning critical period. Nature. 2023;618:790-798. doi:10.1038/s41586-023-06204-3. Animal (mouse) study; do not generalise to humans.

Last reviewed: 7 September 2026. Next review due: 7 March 2027.

Educational content only. This is not medical advice, therapy, or a clinical diagnosis, and it does not encourage illegal activity. It exists to reduce risk for adults making their own decisions. Reviewed for scope by Vladislav Andreev, Certified Psychedelic Coach (Psychedelic Coaching Institute), harm-reduction educator, Barcelona.

Related reading

- What Is Psychedelic Integration? A Plain-Language Primer
- Returning to Work After a Psychedelic Retreat